v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities:    
Net loss $ (110,556) $ (74,908)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 9,294 8,341
Loss (gain) on sale of fixed assets 954 (743)
Non-cash operating lease expense 5,054 5,690
Loss (gain) on extinguishment of debt 3,904 (5,398)
Stock-based compensation expense 10,061 (5,976)
Changes in fair value of financial instruments carried at fair value, net 8,574 11,732
Non-cash credit support expense 265  
Non-cash lease termination expense 5,376  
Amortization of debt discounts and debt issuance costs 1,727 252
Deferred income taxes (380) (287)
Changes in operating assets and liabilities:    
Accounts receivable, net 328 708
Prepaid expenses and other current assets 191 977
Other assets 124 (396)
Accounts payable 2,487 9,530
Due to a related party (403) (3,351)
Accrued expenses and other current liabilities 3,361 9,416
Deferred revenue 531 (4,334)
Operating lease liabilities (5,043) (5,554)
Other liabilities (9) (21)
Cash flows used in operating activities (64,160) (54,322)
Cash flows from investing activities:    
Purchase of property and equipment (5,936) (11,758)
Proceeds from the sale of fixed assets 2,681 10,495
Internal-use software development costs (2,456) (2,346)
Net cash used in investing activities (5,711) (3,609)
Cash flows from financing activities:    
Proceeds from borrowings on convertible notes 65,000 0
Payments of borrowings on convertible notes (4,000) 0
Proceeds from borrowings on long-term debt 3,056 44,234
Principal payments on long-term debt (52,955) (6,566)
Principal payments on Mandatory Convertible Security (38,615)  
Proceeds from issuance of common stock 51,387  
Common shares repurchases for employee tax withholding (380) 0
Proceeds from sales and advances under Share Purchase Agreement 47,183 3,894
Proceeds from (payments on) collateralized borrowings, net of repayment (536) 2,793
Proceeds from borrowings from related parties 0 34,522
Payments of debt issuance costs 0 (1,488)
Payment of finance lease obligations (266) (234)
Proceeds from exercise of warrants 830  
Proceeds from exercise of stock options 255 20
Net cash provided by financing activities 70,959 77,175
Increase in cash, cash equivalents and restricted cash 1,088 19,244
Cash, cash equivalents and restricted cash at beginning of period 21,675 2,431
Cash, cash equivalents and restricted cash at end of period $ 22,763 $ 21,675